Parkit Enterprise Inc.: Parkit Completes Sale of Winnipeg Property and Adds To Investment in PROREIT

Parkit Enterprise Inc. (TSXV: PKT) ("Parkit" or the "Company"), has completed the sale of its remaining property located in Winnipeg, Manitoba ...
Cantech Letter

Parkit Completes Sale of Winnipeg Property and Adds To Investment in PROREIT

Parkit Enterprise Inc. (TSXV: PKT) (“Parkit” or the “Company”), has completed the sale of its remaining property located in ...

Positive Clinical Results from Phase 2 Trial of SGX945 for the Treatment of Behçet's Disease Published in Rheumatology (Oxford)

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and ...

Soligenix Announces Top-line Results of the Phase 2a Study of SGX302 (Synthetic Hypericin) in Patients with Mild-to-Moderate Psoriasis

Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet ...

Provisional Patent Application: Key Benefits and Filing Process

Discover how a Provisional Patent Application protects your invention with the "patent pending" label and learn about its ...

Some patients face hurdles getting HIV prevention drugs. Here's what to know

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.